000 01258 a2200361 4500
005 20250514234550.0
264 0 _c20050908
008 200509s 0 0 eng d
022 _a0022-538X
024 7 _a10.1128/JVI.79.16.10571-10577.2005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDodding, Mark P
245 0 0 _aCapsid processing requirements for abrogation of Fv1 and Ref1 restriction.
_h[electronic resource]
260 _bJournal of virology
_cAug 2005
300 _a10571-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBALB 3T3 Cells
650 0 4 _aCapsid
_xmetabolism
650 0 4 _aDNA-(Apurinic or Apyrimidinic Site) Lyase
_xphysiology
650 0 4 _aGene Products, gag
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLeukemia Virus, Murine
_xphysiology
650 0 4 _aMice
650 0 4 _aNIH 3T3 Cells
650 0 4 _aProteins
_xphysiology
650 0 4 _aVirion
_xphysiology
700 1 _aBock, Michael
700 1 _aYap, Melvyn W
700 1 _aStoye, Jonathan P
773 0 _tJournal of virology
_gvol. 79
_gno. 16
_gp. 10571-7
856 4 0 _uhttps://doi.org/10.1128/JVI.79.16.10571-10577.2005
_zAvailable from publisher's website
999 _c15705234
_d15705234